Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Alice Long

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Diabetes|October 31, 2009
Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjectsS Alice Long, Karen Cerosaletti, Paul L Bollyky, et al.
Diabetologia|October 30, 2020
Weekly injection of IL-2 using an injectable hydrogel reduces autoimmune diabetes incidence in NOD miceNadine Nagy, Gernot Kaber, Michael J Kratochvil, et al.
Communications Biology|September 27, 2023
Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetesJeremy R B Newman, S Alice Long, Cate Speake, et al.
Nature Communications|November 23, 2022
Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomesHamid Bolouri, Rhonda E Ries, Alice E Wiedeman, et al.
Nature Communications|May 30, 2025
Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetesAna Lledó-Delgado, Paula Preston-Hurlburt, Lauren Higdon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-betaPaul L Bollyky, Ben A Falk, S Alice Long, et al.
Science Translational Medicine|March 4, 2021
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individualsEmily K Sims, Brian N Bundy, Kenneth Stier, et al.
The Journal of Clinical Investigation|August 13, 2024
Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetesAna Lledó-Delgado, Paula Preston-Hurlburt, Sophia Currie, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 30, 2021
A simple strategy for sample annotation error detection in cytometry datasetsMegan E Smithmyer, Alice E Wiedeman, David A G Skibinski, et al.
Frontiers in Immunology|July 1, 2025
Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applicationsZhang Cheng, Li-Jie Wang, Yuchi Honaker, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Diabetes|October 31, 2009
Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjectsS Alice Long, Karen Cerosaletti, Paul L Bollyky, et al.
Diabetologia|October 30, 2020
Weekly injection of IL-2 using an injectable hydrogel reduces autoimmune diabetes incidence in NOD miceNadine Nagy, Gernot Kaber, Michael J Kratochvil, et al.
Communications Biology|September 27, 2023
Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetesJeremy R B Newman, S Alice Long, Cate Speake, et al.
Nature Communications|November 23, 2022
Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomesHamid Bolouri, Rhonda E Ries, Alice E Wiedeman, et al.
Nature Communications|May 30, 2025
Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetesAna Lledó-Delgado, Paula Preston-Hurlburt, Lauren Higdon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-betaPaul L Bollyky, Ben A Falk, S Alice Long, et al.
Science Translational Medicine|March 4, 2021
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individualsEmily K Sims, Brian N Bundy, Kenneth Stier, et al.
The Journal of Clinical Investigation|August 13, 2024
Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetesAna Lledó-Delgado, Paula Preston-Hurlburt, Sophia Currie, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 30, 2021
A simple strategy for sample annotation error detection in cytometry datasetsMegan E Smithmyer, Alice E Wiedeman, David A G Skibinski, et al.
Frontiers in Immunology|July 1, 2025
Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applicationsZhang Cheng, Li-Jie Wang, Yuchi Honaker, et al.
Pageof 8